Emergent BioSolutions (NYSE:EBS) Cut to Hold at StockNews.com
StockNews.com cut shares of Emergent BioSolutions (NYSE:EBS – Free Report) from a buy rating to a hold rating in a research report report published on Wednesday. Several other analysts have also recently issued reports on the stock. HC Wainwright reaffirmed a “buy” rating and set a $15.00 price objective on shares of Emergent BioSolutions in […]
